Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes

Documenti analoghi

• Unprecedented high insulin secretion in a healthy human subject after intravenous glucagon-like peptide-1: a case report
  di: Knop, Filip K, et al.
  Pubblicazione: (2014)
• Incretin-Based Therapies: Viewpoints on the way to consensus
  di: Nauck, Michael. A., et al.
  Pubblicazione: (2009)
• Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual β-Cell Function
  di: Kielgast, Urd, et al.
  Pubblicazione: (2011)
• On the role of gallbladder emptying and incretin hormones for nutrient-mediated TSH suppression in patients with type 2 diabetes
  di: Sonne, David P, et al.
  Pubblicazione: (2014)
• Mechanisms of the Incretin Effect in Subjects with Normal Glucose Tolerance and Patients with Type 2 Diabetes
  di: Mari, Andrea, et al.
  Pubblicazione: (2013)